Jeffrey A. Kyle

520 total citations
25 papers, 297 citations indexed

About

Jeffrey A. Kyle is a scholar working on Epidemiology, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Jeffrey A. Kyle has authored 25 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Psychiatry and Mental health and 3 papers in Surgery. Recurrent topics in Jeffrey A. Kyle's work include Atrial Fibrillation Management and Outcomes (2 papers), Sexual function and dysfunction studies (2 papers) and Diabetes Management and Research (2 papers). Jeffrey A. Kyle is often cited by papers focused on Atrial Fibrillation Management and Outcomes (2 papers), Sexual function and dysfunction studies (2 papers) and Diabetes Management and Research (2 papers). Jeffrey A. Kyle collaborates with scholars based in United States, United Kingdom and Sweden. Jeffrey A. Kyle's co-authors include Dana Brown, Jessica W. Skelley, Mary J. Ferrill, Gerald F. Smith, Michael R. Wiley, Wagdy W. Wahba, Ning Chen, Donetta S. Gifford‐Moore, Richard D. Towner and Leonard C. Weir and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Organometallics.

In The Last Decade

Jeffrey A. Kyle

22 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey A. Kyle United States 12 66 63 44 39 38 25 297
C H Gleiter Germany 8 77 1.2× 124 2.0× 98 2.2× 22 0.6× 29 0.8× 13 400
Sum Lam United States 11 64 1.0× 50 0.8× 64 1.5× 10 0.3× 42 1.1× 28 353
Pipasha Biswas United Kingdom 10 44 0.7× 63 1.0× 37 0.8× 7 0.2× 33 0.9× 15 528
Yanli Zhao China 14 141 2.1× 228 3.6× 67 1.5× 7 0.2× 26 0.7× 54 660
Antonio García Fernández Spain 10 48 0.7× 112 1.8× 18 0.4× 17 0.4× 23 0.6× 20 342
Neena Gupta India 11 14 0.2× 36 0.6× 131 3.0× 36 0.9× 27 0.7× 46 363
Martina Chiurazzi Italy 11 37 0.6× 11 0.2× 93 2.1× 9 0.2× 23 0.6× 28 610
Yamato Kato Japan 13 18 0.3× 41 0.7× 33 0.8× 7 0.2× 22 0.6× 25 423
Rob Walker New Zealand 12 41 0.6× 13 0.2× 25 0.6× 11 0.3× 25 0.7× 36 361
Sharon See United States 10 29 0.4× 35 0.6× 30 0.7× 9 0.2× 26 0.7× 21 355

Countries citing papers authored by Jeffrey A. Kyle

Since Specialization
Citations

This map shows the geographic impact of Jeffrey A. Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Kyle more than expected).

Fields of papers citing papers by Jeffrey A. Kyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Kyle. The network helps show where Jeffrey A. Kyle may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Kyle

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Kyle. A scholar is included among the top collaborators of Jeffrey A. Kyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Kyle. Jeffrey A. Kyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kyle, Jeffrey A., et al.. (2025). Scaffolding a clinical debate assignment in an infectious disease pharmacy elective: A mixed methods analysis. Currents in Pharmacy Teaching and Learning. 17(5). 102306–102306.
2.
Kyle, Jeffrey A., et al.. (2023). Managing the Drug-Drug Interaction With Apixaban and Primidone: A Case Report. Hospital Pharmacy. 58(4). 345–349. 2 indexed citations
3.
Kyle, Jeffrey A., et al.. (2022). Evaluating the Impact of a Pharmacist-Led Antimicrobial Stewardship Intervention at Discharge in a Community, Nonteaching Hospital. Annals of Pharmacotherapy. 57(3). 292–299. 2 indexed citations
4.
Wang, Jian, Andrew McCarthy, Xiangnan Dang, et al.. (2022). Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body Dementia. Journal of Parkinson s Disease. 12(6). 1991–2004. 7 indexed citations
5.
Kyle, Jeffrey A., et al.. (2021). Impact of a novel preceptor collaborative advanced pharmacy practice experience curriculum on student-perceived ability and confidence. Currents in Pharmacy Teaching and Learning. 13(8). 1053–1060. 1 indexed citations
6.
Durham, Spencer H., Christopher M. Bland, P. Brandon Bookstaver, et al.. (2021). A Continuing Education Activity Durably Addressed Knowledge Gaps Related to Penicillin Allergies Among Pharmacists and Pharmacy Technicians. Journal of Pharmacy Technology. 38(1). 18–25.
7.
White, C. Whitney, et al.. (2019). Noncarbapenems for the Treatment of Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Bacteria. Southern Medical Journal. 112(8). 438–443.
8.
Skelley, Jessica W., et al.. (2016). Novel oral anticoagulants for heparin-induced thrombocytopenia. Journal of Thrombosis and Thrombolysis. 42(2). 172–178. 23 indexed citations
9.
Kyle, Jeffrey A., et al.. (2015). Time to Guideline-Based Empiric Antibiotic Therapy in the Treatment of Pneumonia in a Community Hospital. Journal of Pharmacy Practice. 29(4). 386–391. 3 indexed citations
10.
Kyle, Jeffrey A., et al.. (2014). A Review of the Efficacy and Safety of Canagliflozin in Elderly Patients with Type 2 Diabetes. The Consultant Pharmacist. 29(5). 335–346. 27 indexed citations
11.
Skelley, Jessica W., et al.. (2014). Dolutegravir. Journal of Pharmacy Technology. 30(6). 216–226. 4 indexed citations
12.
Kyle, Jeffrey A., et al.. (2013). Avanafil for Erectile Dysfunction. Annals of Pharmacotherapy. 47(10). 1312–1320. 28 indexed citations
13.
Skelley, Jessica W., et al.. (2012). Teplizumab for Treatment of Type 1 Diabetes Mellitus. Annals of Pharmacotherapy. 46(10). 1405–1412. 8 indexed citations
14.
Kyle, Jeffrey A., et al.. (2011). Integrating spirituality in patient care: preparing students for the challenges ahead. Currents in Pharmacy Teaching and Learning. 3(4). 260–266. 14 indexed citations
15.
Ferrill, Mary J., Dana Brown, & Jeffrey A. Kyle. (2010). Clinical Versus Statistical Significance: Interpreting P Values and Confidence Intervals Related to Measures of Association to Guide Decision Making. Journal of Pharmacy Practice. 23(4). 344–351. 16 indexed citations
16.
Kyle, Jeffrey A., et al.. (2010). New Drug Approvals: Milnacipran for Treatment of Fibromyalgia. Annals of Pharmacotherapy. 44(9). 1422–1429. 17 indexed citations
17.
Kyle, Jeffrey A., et al.. (2006). Oral Varenicline for Smoking Cessation. Annals of Pharmacotherapy. 41(1). 95–99. 25 indexed citations
18.
Sheehan, Scott M., John J. Masters, Michael R. Wiley, et al.. (2003). A four component coupling strategy for the synthesis of d-phenylglycinamide-derived non-covalent factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(14). 2255–2259. 18 indexed citations
19.
O’Donnell, Martin, et al.. (1995). Palladium-catalyzed reaction of a malonate anion with a glycine cation equivalent: Bis-phosphine ligands and in situ catalyst formation. Tetrahedron Letters. 36(24). 4205–4208. 14 indexed citations
20.
Miller, Roy G., et al.. (1993). Generation of an (alkoxycarbonyl)rhodium complex in an alcohol analog of the water-gas shift reaction. Organometallics. 12(4). 1161–1166. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C H Gleiter Breakdown of academic impact, for papers by Sum Lam Breakdown of academic impact, for papers by Pipasha Biswas Breakdown of academic impact, for papers by Yanli Zhao Breakdown of academic impact, for papers by Antonio García Fernández Breakdown of academic impact, for papers by Neena Gupta Breakdown of academic impact, for papers by Martina Chiurazzi Breakdown of academic impact, for papers by Yamato Kato Breakdown of academic impact, for papers by Rob Walker Breakdown of academic impact, for papers by Sharon See
Rankless by CCL
2026